...some companies are banking on to enhance CAR T efficacy. Torque is starting with the Deep IL-15...
...in clinical trials for cancer. Torque declined to disclose the composition of active IL-15 in Deep IL-15...
...but expects to have its own cellular therapies after that. The first clinical trial with Deep IL-15...

...its lead candidate, Deep IL-15, into the clinic to treat cancer by 1H18. In preclinical studies, Deep IL-15...
...to optimize dose, timing and location in the tumor microenvironment. Torque Therapeutics Inc., Cambridge, Mass. Alicia Parker Deep IL-15 Torque...

...to move its lead candidate, Deep IL-15 , into the clinic by 1H18. In preclinical studies, Deep IL-15...
...global research headquarters for Novartis AG (NYSE:NVS; SIX:NOVN). Torque Therapeutics Inc. , Cambridge, Mass. Elizabeth S. Eaton Deep IL-15 Torque...

...plans to move its lead candidate, Deep IL-15, into the clinic by 1H18. In preclinical studies, Deep IL-15...
...Mass., serves as the global research headquarters for Novartis AG (NYSE:NVS; SIX:NOVN). Elizabeth S. Eaton Merrimack Pharmaceuticals Inc. Deep IL-15 Torque...